Hypothalamic-Pituitary Axis — Comprehensive Study Notes (Lecture 3)
Overview
- Hypothalamic-pituitary axis: key relationships, major peptide/polypeptide hormones, concept of neurosecretion, feedback control, and growth hormone (GH) with insulin-like growth factors (IGFs).
- Focus areas: hypothalamus and pituitary anatomy, inputs to the pituitary, releasing/inhibiting hormones, feedback loops, and the functional roles of anterior, posterior, and intermediate lobes.
Embryology and Anatomy of the Pituitary
- Pituitary is a pea-sized gland located in the sella turcica of the sphenoid bone.
- Embryology:
- Anterior lobe (adenohypophysis) derives from Rathke’s pouch (oral ectoderm).
- Posterior lobe (neurohypophysis) derives from neural tissue (floor of the diencephalon).
- Intermediate lobe (pars intermedia) lies between anterior and posterior lobes.
- The pituitary is a composite organ with three lobes; each lobe is functionally independent but depends on hypothalamic inputs.
- The name “pituitary” historically relates to mucus; anatomical significance is its central role in endocrine control.
Pituitary Anatomy and Key Landmarks
- Anatomy highlights:
- Anterior lobe: pars distalis
- Posterior lobe: pars nervosa
- Intermediate lobe: pars intermedia
- Topographic relationships: hypothalamic region, mamillary body, optic chiasm, hypophyseal stalk, pars tuberalis.
- Blood supply and connections: hypophyseal portal system connects hypothalamus to the anterior pituitary; the posterior pituitary is supplied by systemic circulation and is connected to hypothalamic centers via neural tracts.
- Modes of input to the pituitary:
- Blood-borne hormones in systemic circulation
- Blood-borne hypothalamic releasing/inhibiting factors affecting the anterior lobe
- Neural inputs with hormone carrier proteins (neurophysins) synthesized in the brain, influencing posterior lobe function
- Hypophyseal portal vessels enable transport of hypothalamic releasing hormones to the anterior pituitary
Hypothalamic–Hypophyseal Portal System and Transport
- GnRH-releasing neurons terminate near the primary capillary plexus in the median basal hypothalamus (MBH).
- Releasing hormones are secreted into the median eminence and travel via long portal veins to the anterior pituitary.
- The posterior pituitary hormones are stored and released from neurosecretory granules after axonal transport from hypothalamic nuclei.
Secretion Pathways: Posterior vs. Anterior Pituitary
- Posterior pituitary: does not synthesize its own hormones; stores and releases oxytocin (OT) and vasopressin/ADH (AVP) produced in hypothalamic magnocellular neurons.
- Anterior pituitary: synthesizes and releases its own hormones in response to hypothalamic releasing/inhibiting factors delivered via the portal system.
- Neurohypophysis (posterior) hormones are transported along axons and released into systemic circulation; carriers (neurophysins) bind these hormones for stabilization.
Hypothalamic Control of the Posterior Pituitary
- Two nuclei govern posterior lobular control: Supraoptic nucleus (SON) and Paraventricular nucleus (PVN).
- Hypothalamo-hypophyseal tract conveys signals from SON and PVN to the posterior lobe.
- Posterior lobe then releases OT and AVP into the systemic circulation.
- Major vascular input: inferior hypophyseal artery.
Hormone Summary: Hypothalamic–Hypophyseal System (Structure to Secretion Pathways)
- Releasing hormones/factors (Median eminence): CRH,TRH,GnRH,GHRH,SS,DA
- Anterior pituitary hormones: ACTH,TSH,LH/FSH,GH,PRL
- Transport and circulation:
- Releasing hormones enter systemic portal circulation to anterior pituitary
- Anterior pituitary hormones enter systemic circulation
- Posterior pituitary hormones (OT, AVP, neurophysins) are transported axonally via magnocellular neurons and released systemically
Releasing Hormones/Factors: Conceptual Framework
- Most hypothalamic releasing hormones are stimulatory, but some are inhibitory.
- There is no simple one-to-one correspondence between a single releasing hormone and a single pituitary tropic hormone.
- Example: removal of the hypothalamus disrupts LH, FSH, and TSH release; PRL regulation is distinctive (primarily inhibited by dopamine), and PRL release can be affected differently than other pituitary hormones.
Hormones of the Hypothalamic–Hypophyseal System: Anterior Pituitary (1a)
- LH (Luteinizing hormone)
- Glycoprotein; MWext(LH)=26,000; subunits: LH-α and LH-β
- FSH (Follicle-stimulating hormone)
- Glycoprotein; MWext(FSH)=27,270; subunits: FSH-α and FSH-β
- TSH (Thyroid-stimulating hormone)
- Glycoprotein; MWext(TSH)=28,000; subunits: TSH-α and TSH-β
Hormones of the Hypothalamic–Hypophyseal System: Anterior Pituitary (1b)
- Prolactin (PRL)
- Single-chain polypeptide; MWextPRL=22,000
- Growth hormone (GH)
- Single-chain polypeptide; MWextGH=22,000 (similar to PRL)
- Adrenocorticotropic hormone (ACTH)
- 39 amino acids; product of the pro-opiomelanocortin (POMC) precursor
Pro-opiomelanocortin (POMC) Processing
- POMC is a large precursor protein that yields multiple peptides:
- ACTH (ACTH 1-39)
- β-LPH (β-LPH 1-91)
- α-MSH
- CLIP
- 7-LPH
- β-Endorphin (1-13), (18-39), (1-58), (61-91)
- P-MSH (pro–opiomelanocortin-derived MSH)
- Met-enkephin (41-58), (61-65)
- Note: POMC is a large precursor giving rise to several hormonal and other peptide products.
Hormones of the Hypothalamic–Hypophyseal System: Posterior Pituitary (2)
- Oxytocin (OT) and vasopressin/antidiuretic hormone (AVP/ADH)
- Oxytocin: nonapeptide
- Vasopressin: octapeptide; also called AVP or ADH
- Storage and release:
- Both hormones are stored in neurosecretory granules and bound to neurophysins for transport
- Melanocyte-stimulating hormone (MSH): α-MSH and β-MSH
- In humans, 95% of MSH is α/β-MSH combined
- Historical role: in lower vertebrates, MSH causes skin darkening (opposite effect to melatonin)
Hypothalamic Hormones: Details (Hypothalamus to Pituitary)
- Gonadotropin-releasing hormone (GnRH/LHRH)
- Decapeptide; stimulates release of LH and FSH
- Thyrotropin-releasing hormone (TRH)
- Tripeptide; stimulates release of TSH and prolactin
- Prolactin-releasing factor (PRF) and Prolactin-inhibitory factor (PIF; dopamine)
Growth Hormone Axis: Hypothalamic Control (4a, 4b)
- Growth hormone releasing hormone (GHRH)
- Growth hormone inhibitory hormone (somatostatin)
- A 14-amino-acid peptide; also produced in the pancreas and can lower blood glucose by inhibiting glucagon release
- Corticotrophin-releasing hormone (CRH)
- Produced in the hypothalamus; also produced extra-hypothalamically in some tissues
- GH axis also involves other modulators not listed here, but IGF-I is the principal mediator of many GH actions
Example: Growth Hormone and Insulin-like Growth Factors (IGFs)
- GH acts on bone and metabolism largely through IGFs, particularly IGF-I
- IGF-I and IGF-II bind to IGF-type I receptor; IGF-II can also bind IGF type II receptor
- IGFs can act as endocrine and/or autocrine/paracrine mediators; produced primarily in the liver and circulate bound to IGF-binding proteins
- Skeletal effects:
- Stimulates linear growth before puberty
- Promotes epiphyseal maturation and eventual epiphyseal closure
- Disorders:
- Giantism (gigantism): excessive GH before puberty
- Acromegaly: excessive GH after puberty
- Dwarfism: GH deficiency
- Metabolic effects (major role throughout life):
- Protein metabolism: promotes protein synthesis in liver and skeletal muscle
- Lipid metabolism: promotes lipolysis
- Carbohydrate metabolism: increases blood glucose by decreasing glucose utilization and stimulating hepatic glycogenolysis
- Insulin interaction: insulin-induced hypoglycemia counteracts, GH rises when glucose is lowered by insulin
Regulation of Growth Hormone Production and Secretion
- Metabolic fuels (most important)
- Glucose/insulin balance: hyperglycemia suppresses GH; amino acids stimulate GH; free fatty acids fall with GH stimulation
- Nutritional status:
- Malnutrition tends to rise GH secretion; obesity tends to alter GH dynamics
- Exercise increases GH release
- Hormonal effects: GH and IGF-I provide negative feedback to hypothalamus and pituitary
- Glucocorticoids, estrogens (in excess) influence GH/IGF axis
- CNS inputs:
- Sleep onset, stress, surgery, trauma, anxiety
- Neurotransmitters:
- Adrenergic α and β, serotonin (5-HT), L-Dopa influence GH release; variability in acromegaly
Growth Hormone Secretion: Pattern and Regulation
- GH secretion is rhythmic and pulsatile
- GH pulses are highest during puberty, with nocturnal peaks
- Evidence suggests GH can be progonadotropic in some contexts
Role of Insulin-like Growth Factors (IGF-I and IGF-II)
- IGF-I and IGF-II bind IGF-type I receptor; IGF-II also binds type II receptor (mannose-6-phosphate receptor)
- Actions can be endocrine and/or autocrine/paracrine
- Production largely in the liver; IGFs circulate bound to binding proteins (IGFBPs)
- Many GH actions are mediated via IGF-I
- IGFs regulate cell proliferation (mitogenesis), differentiation, and cellular metabolism
- Forms to note: the two most important are IGF-I and IGF-II
- Hypothalamus provides GHRH/GHIH (somatostatin) signals to pituitary
- Pituitary secretes GH in response to GHRH and is inhibited by somatostatin
- GH acts on the liver to produce IGF-I; IGF-I then promotes tissue growth and metabolism
- IGFs feedback to regulate hypothalamic and pituitary function via IGF receptors and binding proteins
- Net effect: GH-IGF axis coordinates growth, metabolism, and energy homeostasis
Connections to Foundational Principles and Real-World Relevance
- Hypothalamic–pituitary axis as a classic example of neuroendocrine control and feedback loops
- Hierarchical control: hypothalamic releasing hormones regulate pituitary output, which in turn regulates peripheral endocrine glands and organ systems
- Negative feedback loops (long, short, ultra-short) maintain hormonal balance and prevent over-secretion
- Clinical relevance: disorders of GH/IGF axis (gigantism, acromegaly, acromegalic features, dwarfism), thyroid axis (TSH), adrenal axis (ACTH), and reproductive axis (LH/FSH) illustrate integration of endocrine systems in growth, metabolism, and reproduction
- LH molecular weight: MWextLH=26,000
- FSH molecular weight: MWextFSH=27,270
- TSH molecular weight: MWextTSH=28,000
- PRL molecular weight: MWextPRL=22,000
- GH molecular weight: MWextGH=22,000
- ACTH: peptide of 39 amino acids (ACTH 1-39) derived from POMC
- POMC yields multiple peptides; examples include: ACTH (1-39), β-LPH (1-91), α-MSH, CLIP, 7-LPH, β-Endorphin (1-13), (18-39), (1-58), (61-91), P-MSH, Met-enkephin (41-58), (61-65)
- GnRH: decapeptide (10 amino acids)
- Somatostatin: 14 amino acids
Quick Reference: Key Terms
- GnRH (Gonadotropin-releasing hormone)
- TRH (Thyrotropin-releasing hormone)
- GHRH (Growth hormone-releasing hormone)
- GHIH / SS (Somatostatin)
- CRH (Corticotropin-releasing hormone)
- PRF (Prolactin-releasing factor)
- PIF (Prolactin-inhibitory factor, dopamine)
- POMC (Pro-opiomelanocortin)
- IGF-I and IGF-II (Insulin-like growth factors)
- Neurophysins (carrier proteins for neurohormones)
- Magnocellular vs. parvocellular neurons (hypothalamic origin of posterior vs. anterior hormone control)
Summary Takeaways
- The hypothalamic–pituitary axis is a coordinated network where hypothalamic hormones regulate anterior/pituitary outputs and posterior pituitary hormones are released directly from hypothalamic neurons.
- GH has diverse roles: direct metabolic effects and indirect growth effects via IGFs, with a pulsatile secretion pattern and strong developmental modulation during puberty.
- Feedback regulation is multi-layered: long-loop (hormone to hypothalamus/pituitary), short-loop (tropic hormone to hypothalamus), and ultra-short-loop (GnRH to GnRH) as a conceptual framework for endocrine homeostasis.
- The POMC precursor is a key hub that gives rise to multiple biologically active peptides, including ACTH and MSH derivatives, illustrating how a single gene product can diversify to regulate multiple systems.